THE APPLICATION OF THE NATIONAL INSTITUTE OF CLINICAL EXCELLENCE GUIDELINES FOR TREATMENT OF METASTATIC RENAL CELL CARCINOMA IN THE UNITED KINGDOM: FRIEND OR FOE?

Thomas Powles; Rob Jones; Simon Chowdhury; Jonathan Shamash; Mark Mantle; Louise Lim; Tom Hutson

doi:10.1111/j.1464-410X.2010.09466.x

THE APPLICATION OF THE NATIONAL INSTITUTE OF CLINICAL EXCELLENCE GUIDELINES FOR TREATMENT OF METASTATIC RENAL CELL CARCINOMA IN THE UNITED KINGDOM: FRIEND OR FOE?

Thomas Powles^*, Rob Jones, Simon Chowdhury, Jonathan Shamash, Mark Mantle, Louise Lim, Tom Hutson

^*Corresponding author for this work

King's College London

Research output: Contribution to journal › Editorial › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	453-457
Number of pages	5
Journal	BJU International
Volume	106
Issue number	4
DOIs	https://doi.org/10.1111/j.1464-410X.2010.09466.x
Publication status	Published - Aug 2010

Keywords

sunitinib
NICE
metastatic renal cell carcinoma
PHASE-III TRIAL
INTERFERON-ALPHA
TARGETED THERAPY
DOUBLE-BLIND
SUNITINIB
EFFICACY
SAFETY

Access to Document

10.1111/j.1464-410X.2010.09466.x

Cite this

@article{75648235025b41f1bdc39c4f72cb8515,

title = "THE APPLICATION OF THE NATIONAL INSTITUTE OF CLINICAL EXCELLENCE GUIDELINES FOR TREATMENT OF METASTATIC RENAL CELL CARCINOMA IN THE UNITED KINGDOM: FRIEND OR FOE?",

keywords = "sunitinib, NICE, metastatic renal cell carcinoma, PHASE-III TRIAL, INTERFERON-ALPHA, TARGETED THERAPY, DOUBLE-BLIND, SUNITINIB, EFFICACY, SAFETY",

author = "Thomas Powles and Rob Jones and Simon Chowdhury and Jonathan Shamash and Mark Mantle and Louise Lim and Tom Hutson",

year = "2010",

month = aug,

doi = "10.1111/j.1464-410X.2010.09466.x",

language = "English",

volume = "106",

pages = "453--457",

journal = "BJU International",

issn = "1464-4096",

publisher = "Wiley-Blackwell",

number = "4",

}

TY - JOUR

T1 - THE APPLICATION OF THE NATIONAL INSTITUTE OF CLINICAL EXCELLENCE GUIDELINES FOR TREATMENT OF METASTATIC RENAL CELL CARCINOMA IN THE UNITED KINGDOM

T2 - FRIEND OR FOE?

AU - Powles, Thomas

AU - Jones, Rob

AU - Chowdhury, Simon

AU - Shamash, Jonathan

AU - Mantle, Mark

AU - Lim, Louise

AU - Hutson, Tom

PY - 2010/8

Y1 - 2010/8

KW - sunitinib

KW - NICE

KW - metastatic renal cell carcinoma

KW - PHASE-III TRIAL

KW - INTERFERON-ALPHA

KW - TARGETED THERAPY

KW - DOUBLE-BLIND

KW - SUNITINIB

KW - EFFICACY

KW - SAFETY

U2 - 10.1111/j.1464-410X.2010.09466.x

DO - 10.1111/j.1464-410X.2010.09466.x

M3 - Editorial

SN - 1464-4096

VL - 106

SP - 453

EP - 457

JO - BJU International

JF - BJU International

IS - 4

ER -